The Efficacy of Light Therapy in the Treatment of Seasonal Affective Disorder: A Meta-Analysis of Randomized Controlled Trials
| Autor: | Luca Cambioli, Dietmar Winkler, Arkadiusz Komorowski, Michaela-Elena Friedrich, Edda Pjrek, Siegfried Kasper, Markus Dold, Fiona Jäger, Rupert Lanzenberger |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Light therapy medicine.medical_specialty medicine.medical_treatment Placebo law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Internal medicine medicine Humans 030212 general & internal medicine Applied Psychology Randomized Controlled Trials as Topic Psychiatric Status Rating Scales business.industry Seasonal Affective Disorder General Medicine Publication bias Phototherapy 030227 psychiatry Clinical trial Psychiatry and Mental health Clinical Psychology Treatment Outcome Strictly standardized mean difference Relative risk Meta-analysis business |
| Zdroj: | Psychotherapy and Psychosomatics. 89:17-24 |
| ISSN: | 1423-0348 0033-3190 |
| DOI: | 10.1159/000502891 |
| Popis: | Background: Bright light therapy (BLT) has been used as a treatment for seasonal affective disorder (SAD) for over 30 years. This meta-analysis was aimed to assess the efficacy of BLT in the treatment of SAD in adults. Method: We performed a systematic literature search including randomized, single- or double-blind clinical trials investigating BLT (≥1,000 lx, light box or light visor) against dim light (≤400 lx) or sham/low-density negative ion generators as placebo. Only first-period data were used from crossover trials. The primary outcome was the post-treatment depression score measured by validated scales, and the secondary outcome was the rate of response to treatment. Results: A total of 19 studies finally met our predefined inclusion criteria. BLT was superior over placebo with a standardized mean difference of –0.37 (95% CI: –0.63 to –0.12) for depression ratings (18 studies, 610 patients) and a risk ratio of 1.42 (95% CI: 1.08–1.85) for response to active treatment (16 studies, 559 patients). We found no evidence for a publication bias, but moderate heterogeneity of the studies and a moderate-to-high risk of bias. Conclusions: BLT can be regarded as an effective treatment for SAD, but the available evidence stems from methodologically heterogeneous studies with small-to-medium sample sizes, necessitating larger high-quality clinical trials. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|